Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat
- 1 June 2001
- journal article
- research article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 12 (8) , 1769-1772
- https://doi.org/10.1097/00001756-200106130-00050
Abstract
3-Nitropropionic acid (3NP) is a succinate dehydrogenase inhibitor classically used to create animal models of Huntington's disease (HD). However, the effects of this neurotoxin are highly variable in the Sprague–Dawley rat strain, impeding the interest of such model in neuroprotection assays. In the present study, we found that continuous s.c. infusion of 3NP in the Lewis rat strain produces homogeneous clinical impairments as well as highly reproducible striatal lesions according to their location and size. More especially, using quantitative reconstructions, we have determined, after 5 days of treatment, that the lesion was topologically reproducible in the lateral part of the striatum in all tested rats. Thus, 3NP-treated Lewis rat provides an improved animal model for testing neuroprotective strategies in HD.Keywords
This publication has 16 references indexed in Scilit:
- Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studiesNeuroscience, 2000
- The Striatum Is the Most Vulnerable Region in the Brain to Mitochondrial Energy Compromise: A Hypothesis to Explain Its Specific VulnerabilityJournal of Neurotrauma, 2000
- In situ examination of tyrosine hydroxylase activity in the rat locus coeruleus using (3?,5?)-[3H2]-?-fluoromethyl-tyrosine as substrate of the enzymeSynapse, 2000
- Metabolic Compromise with Systemic 3-Nitropropionic Acid Produces Striatal Apoptosis in Sprague–Dawley Rats but Not in BALB/c ByJ MiceExperimental Neurology, 1998
- 3-Nitropropionic acidʼs lethal tripletNeuroReport, 1998
- Early Loss of Neostriatal Striosome Neurons in Huntingtonʼs DiseaseJournal of Neuropathology and Experimental Neurology, 1995
- Striatal Restricted Adenosine A2 Receptor (RDC8) Is Expressed by Enkephalin but Not by Substance P Neurons: An In Situ Hybridization Histochemistry StudyJournal of Neurochemistry, 1991
- Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic studyDevelopmental Brain Research, 1991
- Neuropathological Classification of Huntingtonʼs DiseaseJournal of Neuropathology and Experimental Neurology, 1985
- BASAL GANGLIA DEGENERATION, MYELIN ALTERATIONS, AND ENZYME INHIBITION INDUCED IN MICE BY THE PLANT TOXIN 3‐NITROPROPANOIC ACIDNeuropathology and Applied Neurobiology, 1982